NexGel (NXGL) Competitors $2.22 -0.01 (-0.45%) Closing price 09/5/2025 03:59 PM EasternExtended Trading$2.24 +0.01 (+0.68%) As of 09/5/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NXGL vs. APYX, LUNG, TELA, NTRB, VANI, QTI, ICCM, CTSO, SRTS, and SURGShould you be buying NexGel stock or one of its competitors? The main competitors of NexGel include Apyx Medical (APYX), Pulmonx (LUNG), TELA Bio (TELA), Nutriband (NTRB), Vivani Medical (VANI), QT Imaging (QTI), IceCure Medical (ICCM), Cytosorbents (CTSO), Sensus Healthcare (SRTS), and SurgePays (SURG). These companies are all part of the "medical equipment" industry. NexGel vs. Its Competitors Apyx Medical Pulmonx TELA Bio Nutriband Vivani Medical QT Imaging IceCure Medical Cytosorbents Sensus Healthcare SurgePays Apyx Medical (NASDAQ:APYX) and NexGel (NASDAQ:NXGL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk. Do institutionals and insiders believe in APYX or NXGL? 55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 15.2% of Apyx Medical shares are held by company insiders. Comparatively, 20.6% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk and volatility, APYX or NXGL? Apyx Medical has a beta of 1.43, indicating that its stock price is 43% more volatile than the S&P 500. Comparatively, NexGel has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500. Does the media favor APYX or NXGL? In the previous week, Apyx Medical's average media sentiment score of 0.00 equaled NexGel'saverage media sentiment score. Company Overall Sentiment Apyx Medical Neutral NexGel Neutral Is APYX or NXGL more profitable? NexGel has a net margin of -25.02% compared to Apyx Medical's net margin of -37.11%. NexGel's return on equity of -49.37% beat Apyx Medical's return on equity.Company Net Margins Return on Equity Return on Assets Apyx Medical-37.11% -158.22% -28.30% NexGel -25.02%-49.37%-25.68% Which has better valuation and earnings, APYX or NXGL? NexGel has lower revenue, but higher earnings than Apyx Medical. NexGel is trading at a lower price-to-earnings ratio than Apyx Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioApyx Medical$48.10M1.54-$23.46M-$0.45-4.36NexGel$8.69M2.06-$3.28M-$0.40-5.55 Do analysts recommend APYX or NXGL? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Apyx Medical 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.67NexGel 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNexGel beats Apyx Medical on 7 of the 13 factors compared between the two stocks. Get NexGel News Delivered to You Automatically Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NXGL vs. The Competition Export to ExcelMetricNexGelMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.99M$7.00B$5.77B$9.91BDividend YieldN/A1.22%6.71%4.52%P/E Ratio-5.5526.4775.5426.08Price / Sales2.0661.83480.4288.33Price / CashN/A21.9036.9659.01Price / Book2.474.9911.446.09Net Income-$3.28M$176.38M$3.28B$266.14M7 Day Performance-9.39%-0.03%0.96%0.34%1 Month Performance-12.60%4.42%7.82%4.42%1 Year Performance-17.16%10.68%62.64%26.17% NexGel Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NXGLNexGel0.4277 of 5 stars$2.22-0.4%N/A-21.8%$17.99M$8.69M-5.5510APYXApyx Medical1.4117 of 5 stars$1.92-3.5%N/A+50.8%$72.61M$48.10M-4.27270Positive NewsGap DownLUNGPulmonx3.5447 of 5 stars$1.73+1.2%$7.66+343.0%-74.9%$70.50M$83.79M-1.21250News CoverageTELATELA Bio2.0933 of 5 stars$1.74-2.2%$4.50+158.6%-42.8%$68.94M$69.30M-1.55120Positive NewsNTRBNutriband2.4007 of 5 stars$6.17-4.6%$13.00+110.7%+53.0%$68.80M$2.14M-6.8610Short Interest ↑Gap DownVANIVivani Medical2.8736 of 5 stars$1.16+0.9%$4.00+244.8%+5.7%$68.72MN/A-2.5820News CoverageAnalyst ForecastShort Interest ↓QTIQT ImagingN/A$2.52+3.3%N/A+283.4%$68.38M$4.00M0.00N/APositive NewsICCMIceCure Medical3.4605 of 5 stars$1.08-3.6%$2.39+120.8%+61.1%$63.39M$2.79M-6.7560News CoverageShort Interest ↓High Trading VolumeCTSOCytosorbents2.1012 of 5 stars$0.95+0.7%$5.50+478.8%-5.3%$59.64M$35.60M-5.59220Gap DownSRTSSensus Healthcare1.9435 of 5 stars$3.38-0.3%$8.00+136.7%-49.0%$55.57M$41.81M-56.3340SURGSurgePays2.5192 of 5 stars$2.71+0.4%$9.00+232.1%+95.7%$55.37M$60.88M-1.0940Short Interest ↑ Related Companies and Tools Related Companies APYX Alternatives LUNG Alternatives TELA Alternatives NTRB Alternatives VANI Alternatives QTI Alternatives ICCM Alternatives CTSO Alternatives SRTS Alternatives SURG Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NXGL) was last updated on 9/6/2025 by MarketBeat.com Staff From Our Partners6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredWarren Buffett's Strangest AI InvestmentTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredOdd trade could help investors secure their wealth in 2025The most profitable phrase you’ve never heard of... Have you heard of 310F? This simple string of code coul...Eagle Publishing | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexGel, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexGel With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
